İlhami Berber
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Hematology 35
- Hematopoietic Stem Cell Transplantation 19
- Multiple Myeloma Research and Treatments 8
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 6
- Genetics 18
- Hemoglobinopathies and Related Disorders 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Mehmet Ali Erkurt (53 shared papers)Emın Kaya (42 shared papers)İrfan Kuku (44 shared papers)Mustafa Köroğlu (15 shared papers)Mehmet Sinan Dal (13 shared papers)Fevzi Altuntaş (13 shared papers)Sinem Namdaroğlu (8 shared papers)Abdulkadir Baştürk (8 shared papers)
In The Last Decade
İlhami Berber
54 papers receiving 439 citations
Peers
Comparison fields: 5 of 81
- Hematology 123
- Infectious Diseases 189
- Obstetrics and Gynecology 48
- Genetics 57
- Oncology 133
Countries citing papers authored by İlhami Berber
This map shows the geographic impact of İlhami Berber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlhami Berber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlhami Berber more than expected).
Fields of papers citing papers by İlhami Berber
This network shows the impact of papers produced by İlhami Berber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlhami Berber. The network helps show where İlhami Berber may publish in the future.
Co-authors
The 25 scholars most cited alongside İlhami Berber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2020 | 41 | |
| 3 | 2014 | 25 | |
| 4 | 2020 | 25 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 24 | |
| 7 | 2014 | 18 | |
| 8 | 2014 | 18 | |
| 9 | Thrombocytopenia in Adults: Review Article | 2012 | 17 |
| 10 | 2020 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2015 | 13 | |
| 13 | 2013 | 11 | |
| 14 | 2019 | 11 | |
| 15 | Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience. | 2015 | 9 |
| 16 | 2016 | 9 | |
| 17 | 2021 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2015 | 5 | |
| 20 | 2021 | 4 |
About İlhami Berber
İlhami Berber is a scholar working on Hematology, Genetics, Immunology, Oncology and Infectious Diseases, having authored 66 papers that have together received 450 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (19 papers), Multiple Myeloma Research and Treatments (8 papers), COVID-19 Clinical Research Studies (8 papers), Platelet Disorders and Treatments (7 papers), Hemoglobinopathies and Related Disorders (6 papers), Blood groups and transfusion (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (123 citations), Infectious Diseases (189 citations), Obstetrics and Gynecology (48 citations), Genetics (57 citations) and Oncology (133 citations). İlhami Berber has collaborated with scholars based in Türkiye, Cambodia and Cyprus. Frequent co-authors include Mehmet Ali Erkurt, Emın Kaya, İrfan Kuku, Mustafa Köroğlu, Mehmet Sinan Dal, Fevzi Altuntaş, Sinem Namdaroğlu, Abdulkadir Baştürk, Burhan Turgut and Tuğçe Nur Yiğenoğlu. Their work appears in journals such as Journal of Clinical Apheresis, Journal of the National Medical Association, Geriatrics and gerontology international, Blood Coagulation & Fibrinolysis and International Journal of COPD.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.